Equities

Eris Lifesciences Ltd

Eris Lifesciences Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,374.20
  • Today's Change6.20 / 0.45%
  • Shares traded35.62k
  • 1 Year change+45.11%
  • Beta0.7325
Data delayed at least 15 minutes, as of Nov 22 2024 09:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Eris Lifesciences Limited is an India-based pharmaceutical company. The Company is engaged in the manufacture and marketing of pharmaceutical products. The Company has a presence in major therapies like oral anti-diabetes, insulins, cardiovascular, vitamins/minerals and dermatology. Its flagship therapies include oral anti-diabetes, cardiovascular disease (CVD) and vitamins, minerals and nutrients (VMN). Its emerging therapies consist of dermatology, insulins, women’s health, central nervous system (CNS), oncology and nephrology. Its portfolio of brands includes Glimisave, Eritel, LNBloc, Olmin, Crevast, Atorsave, Gluxit, Renerve, Zomelis, Cosvate, Tayo, Cyblex, Remylin, Tendia, Rabonik, Ginkocer, Psorid, Raricap, Serlift, and Onabet, among others. Its patient care initiatives (PCI) platform provides various healthcare solutions to its patients. The Company has a manufacturing plant located in Guwahati, Assam.

  • Revenue in INR (TTM)24.98bn
  • Net income in INR3.48bn
  • Incorporated2007
  • Employees3.08k
  • Location
    Eris Lifesciences Ltd7th Floor, Commerce House IV,,Beside Shell Petrol Pump, 100 Feet Road,AHMEDABAD 380054IndiaIND
  • Phone+91 7 969661000
  • Fax+91 7 930179404
  • Websitehttps://eris.co.in/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
ERIS:NSI since
announced
Transaction
value
Chemman Labs Pvt LtdDeal completed02 Aug 202402 Aug 2024Deal completed22.37%12.54m
Biocon Biologics Ltd-BFI BusinessDeal completed14 Mar 202414 Mar 2024Deal completed64.67%149.96m
Swiss Parenterals LtdDeal completed13 Feb 202413 Feb 2024Deal completed51.68%76.84m
Data delayed at least 15 minutes, as of Nov 22 2024 09:59 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Granules India Ltd44.78bn4.87bn132.05bn4.12k27.133.8518.922.9520.0820.08184.59141.410.83721.365.1410,863,290.009.1110.6814.0516.1859.3948.8310.8811.820.71526.880.24258.96-0.12314.61-21.5411.386.388.45
Glenmark Life Sciences Ltd22.05bn4.24bn132.34bn2.01k31.345.2127.536.0034.4734.47179.44207.170.73041.462.7910,947,850.0014.0318.2816.6929.9954.9253.4019.2120.233.03380.550.006326.375.6420.830.84119.2169.11--
Strides Pharma Science Ltd44.10bn1.77bn138.27bn3.07k78.246.0837.203.1419.2225.15479.84247.160.71551.503.5714,389,290.002.79-1.685.43-2.9760.1951.393.91-3.360.63551.520.5103--9.8313.2143.57---18.52-3.58
Sanofi India Ltd21.92bn3.60bn139.95bn2.17k38.86--35.226.38156.36199.60951.86--------10,083,720.00--22.42--30.2153.9455.5216.4321.03--348.40--135.492.920.573-2.859.64-10.3414.73
Marksans Pharma Ltd23.79bn3.47bn140.10bn2.00k40.356.1432.555.897.667.6652.5350.340.91051.654.7511,893,400.0013.3014.6215.7818.5255.3250.5214.6114.032.9731.250.07926.1717.5616.8417.8032.6273.8664.38
Caplin Point Laboratories Ltd18.31bn4.94bn147.68bn859.0030.025.8126.388.0764.7364.73240.10334.540.68612.283.4021,312,920.0018.6219.8321.3622.8258.7253.3827.1425.395.07932.860.00099.0615.5021.1721.4820.9517.4717.84
Astrazeneca Pharma India Ltd14.85bn819.20m157.64bn940.00192.4523.20153.6210.6232.7632.76593.93271.741.272.5210.6315,792,680.006.9911.7811.4419.6244.8854.645.5210.271.44134.820.024625.6229.1712.2162.6624.29-10.46--
Jubilant Pharmova Ltd69.20bn5.93bn179.04bn995.0030.243.0118.522.5937.3837.38436.41375.040.59341.758.1569,544,720.005.052.966.013.5568.5068.478.515.131.202.510.34224.736.70-5.95226.43-33.086.482.13
Eris Lifesciences Ltd24.98bn3.48bn186.04bn3.08k53.456.7129.877.4525.5725.57183.35203.740.45852.905.968,110,753.006.7313.428.3916.8077.0379.9814.6924.960.85993.410.4626--19.2315.392.576.1527.72--
Neuland Laboratories Ltd.15.28bn2.80bn189.47bn1.65k67.7513.6555.1412.40217.98217.981,191.201,081.520.8472.144.859,273,565.0015.509.2520.0312.7152.1447.8118.3011.991.4031.560.07287.1330.8418.5183.5178.7617.8863.45
Wockhardt Ltd29.49bn-2.88bn190.86bn2.39k--5.31--6.47-19.85-19.85201.29221.320.3931.874.1912,318,300.00-3.93-4.56-6.33-8.2959.1055.26-10.00-12.700.56770.2470.3869--5.55-4.7317.17---4.71--
Alembic Pharmaceuticals Ltd63.57bn6.47bn204.00bn14.86k31.564.1722.063.2132.8832.88323.14248.680.9290.93665.434,278,678.009.4510.7213.3214.2573.8465.9810.1712.470.805712.620.179128.2910.199.6280.071.05-15.5914.87
Concord Biotech Ltd10.86bn3.28bn208.31bn1.38k53.7613.1054.5819.1937.0437.04114.79152.020.6551.113.557,884,886.0019.78--21.82--76.00--30.20--4.83194.730.0022--19.20--28.33------
Pfizer Ltd22.38bn6.18bn234.75bn1.72k37.996.2634.5810.49135.06135.06489.19819.900.52881.8311.1613,004,360.0014.6014.2217.0517.7165.0061.3727.6124.054.3046.210.026782.67-9.551.05-11.645.1433.359.24
Emcure Pharmaceuticals Ltd72.56bn5.67bn242.76bn11.15k42.275.8925.283.3530.3730.37389.63217.790.9781.803.966,510,068.008.027.1413.5513.9361.1159.298.207.810.95495.250.21650.0011.237.14-6.3621.35-5.93--
Natco Pharma Ltd.45.61bn19.45bn246.23bn4.02k12.663.4411.545.40108.58108.58254.65399.190.62910.89283.5711,356,080.0026.8212.3330.8514.2585.4773.0542.6325.164.19108.700.028318.9647.7213.8194.0916.59-4.7114.87
Data as of Nov 22 2024. Currency figures normalised to Eris Lifesciences Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

19.68%Per cent of shares held by top holders
HolderShares% Held
HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 15 Dec 20236.98m5.13%
UTI Asset Management Co. Ltd. (Investment Management)as of 03 May 20246.78m4.98%
Franklin Templeton Asset Management (India) Pvt Ltd.as of 31 Oct 20244.48m3.29%
The Vanguard Group, Inc.as of 06 Nov 20242.09m1.54%
Templeton Asset Management Ltd.as of 30 Sep 20241.92m1.41%
Plutus Wealth Management LLPas of 30 Sep 20231.50m1.10%
Tata AIA Life Insurance Co. Ltd.as of 31 Oct 2024899.08k0.66%
Aditya Birla Sun Life Amc Ltd. (Investment Management)as of 31 Oct 2024848.88k0.62%
DSP Asset Managers Pvt. Ltd.as of 31 Oct 2024668.45k0.49%
Bank of India Investment Managers Pvt Ltd.as of 31 Oct 2024624.74k0.46%
More ▼
Data from 30 Sep 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.